Holiday Wish-Lists and Watch-Outs From Regulatory Leaders (Ep. 5 on The Pharmcast)

December 8, 2016 Jim Combs

In this episode of The Pharmcast, we asked two of our top regulatory policy Experts to give us their holiday wish-lists and top things to watch for in the upcoming year.

Leading the discussion is Dr. Tim Franson, who is the former VP of Global Regulatory Affairs and Global Patient Safety for Eli Lilly & Company, current Chairman of the Board for the Critical Path Institute, and YourEncore's Chief Medical Officer.

Joining him is Peter J. Pitts, former FDA Associate Commissioner and current President for the Center for Medicine in the Public Interest, a policy institute he founded in 2004. Peter was named one of the "300 Most Powerful People in American Healthcare" by Modern Healthcare Magazine, and frequently contributes to national media outlets – including CNBC, Fox News and the Wall Street Journal.

As Dr. Franson and Peter discuss what they're hoping for under the tree this year – and what situations could potentially turn into lumps of coal – they fixate on the letter "P" and all the changes, from "people" to "policy," that could be coming to the industry in the next year.

Join us in Episode 5 of The Pharmcast as Dr. Franson and Peter begin to dissect these questions and what they're wishing for, among these and several other P-related hot topics for the upcoming year.

The Pharmcast is now available for download on iTunes, Google Play, and Stitcher. If you like what you hear, share it with your friends and write a review or give us a rating on your podcast store.

From Big Pharma to Biotech C-Suite: Industry and Career Insights from Dr. June Almenoff (Ep. 6 on The Pharmcast)

This week on The Pharmcast, we talk with Dr. June Almenoff, former President, Chief Medical Of...

Billion Dollar Bets: Lessons on Innovation from a BMS Chief Scientific Officer, Dr. Elliott Sigal (Ep. 4 on The Pharmcast)

Each week in The Pharmcast, we talk with top industry experts from our network or beyond ab...

THE EXPERTS ON EXPERTS.

Holiday Wish-Lists and Watch-Outs From Regulatory Leaders (Ep. 5 on The Pharmcast)

Previous Article

Next Article

Holiday Wish-Lists and Watch-Outs From Regulatory Leaders (Ep. 5 on The Pharmcast)

Previous Article

Next Article

Related Content

Learn more from Regina Shanklin on how maximizing engagement with your audience and patients will help increase the relevance of your brand communications

Learn more from Regina Shanklin on how being useful to your audience and patients will help increase the relevance of your brand communications

Learn more from Regina Shanklin on how being completely understandable to your audience will help increase the relevance of your brand communications

Learn more from Regina Shanklin on how seeing things from the patient’s point-of-view will help you meet them where they are and increase the relevance of your brand communications

Raphael G. Ognar discusses the overlying challenges biopharma organizations have and how Virtual Development can save the day.

Joseph Lamendola, PhD discusses the challenges many biopharma companies face and how Virtual Development can help create solutions.

Design-thinking in innovation is essential to creating the passionate buyers that will flock to buy your product or service and remain loyal over time.

Joseph Lamendola, PhD and Timothy Franson, MD walk through the requirements for kickstarting a new development program in a Biopharma organization.

Millennials, Gen Xers, and Baby Boomers can actually pleasantly co-exist in today's workplace – and more importantly, even collaborate and produce incredible results together.

When “matches” are made based on algorithms, reverse auctions, and keywords, the human connection is lost. But it is human connection that fuels individual inspiration, rejuvenation, reinvention...

In the frenzy to capitalize on this trend, technology is rapidly becoming the lead “solution” for connecting freelancers and employers.

Today’s prevailing wisdom is that R&D costs are on the rise while ROI on those investments are down. The Tufts Center for the Study of Drug Development puts the total costs of new drug around...

YourEncore experts Minnie Baylor-Henry, Darryl Glover, Donna Godward, and Vic Chance discuss the promise of Blockchain to address key issues within the Medical Devices industry.

In an effort to expand our thought leadership, highlight Experts, and engage our Expert Community, we collaborated with YourEncore Expert, Mike Wiseman, to participate in our Q&A series...

In an effort to expand our thought leadership, highlight Experts, and engage our Expert Community, we collaborated with YourEncore Expert, John Carpenter, to participate in our Q&A...

The Wall Street Journal recently published an article describing the experience of Independent Contractors as that of “second-class office workers." It painted a dark, and, in my...